结缔组织病对乳房再造的影响:一项全国数据库分析
基于美国全国住院患者样本数据库2010至2014年数据的回顾性分析,纳入19,496例即刻自体乳房再造患者(结缔组织病357例 vs 非结缔组织病19,139例)和23,048例即刻植入物乳房再造患者(431例 vs 22,617例)。结缔组织病患者自体再造后感染、伤口裂开和出血率更高,植入物再造后伤口裂开率更高且住院时间更长;多因素分析显示结缔组织病分别是自体再造出血和植入物再造伤口裂开的独立危险因素。
要点
- 自体乳房再造中,结缔组织病患者感染率2.8% vs 0.8%,伤口裂开1.4% vs 0.4%,出血6.7% vs 3.5%,三组差异均有统计学意义。
- 植入物乳房再造中,结缔组织病患者伤口裂开/并发症发生率为2.3% vs 0.6%,住院时间2.31天 vs 2.07天,差异均有统计学意义。
- 多因素分析显示,结缔组织病是自体乳房再造出血(OR 1.568,95%CI 1.019-2.412)和植入物乳房再造伤口裂开(OR 4.084,95%CI 2.101-7.939)的独立危险因素。
核心结论
- 接受自体乳房再造的结缔组织病患者感染、伤口裂开和出血率显著更高,接受植入物乳房再造者伤口裂开率显著更高。
- 结缔组织病似乎是自体乳房再造出血和植入物乳房再造伤口裂开的独立危险因素。
- 作者认为该信息可能有助于临床医生在为患者决定是否行乳房再造时意识到这种升高的风险。
研究设计与样本
- 回顾性分析美国医疗成本与利用项目全国住院患者样本数据库(HCUP NIS)2010至2014年数据。
- 纳入18岁及以上因即刻自体或植入物乳房再造住院的患者。
- 结缔组织病定义为系统性红斑狼疮、类风湿关节炎、系统性硬化症、硬皮病、雷诺现象、银屑病关节炎或结节病。
- 连续变量采用独立t检验/Wilcoxon-Mann-Whitney检验,分类变量采用Pearson χ²/Fisher精确检验。
- 结局分析采用多因素线性回归(连续变量)和多因素logistic回归(分类变量)。
主要发现
- 自体乳房再造患者共19,496例,其中结缔组织病357例、非结缔组织病19,139例(2010-2014年)。
- 自体再造中,结缔组织病组 vs 非结缔组织病组:感染2.8% vs 0.8%(P<0.001),伤口裂开1.4% vs 0.4%(P=0.019),出血(含出血和血肿)6.7% vs 3.5%(P<0.001)。
- 自体再造多因素分析中,结缔组织病为出血的独立危险因素(OR 1.568,95%CI 1.019-2.412)。
- 植入物乳房再造患者共23,048例,其中结缔组织病431例、非结缔组织病22,617例(2010-2014年)。
- 植入物再造中,结缔组织病组 vs 非结缔组织病组:伤口裂开/并发症2.3% vs 0.6%(P<0.001),住院时间2.31天 vs 2.07天(P<0.001)。
临床怎么用
- 作者认为该信息可能有助于临床医生在为患者决定是否行乳房再造时意识到结缔组织病患者术后并发症风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with connective tissue diseases (CTD), or collagen vascular diseases, are at risk of potentially higher morbidity after surgical procedures. We aimed to investigate the complication profile in CTD versus non-CTD patients who underwent breast reconstruction on a national scale. METHODS: A retrospective analysis of the Healthcare Cost and Utilization Project NIS Database between 2010 and 2014 was conducted for patients 18 years or older admitted for immediate autologous or implant breast reconstruction. Connective tissue disease was defined as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, scleroderma, Raynaud phenomenon, psoriatic arthritis, or sarcoidosis. Independent t test/Wilcoxon-Mann-Whitney was used to compare continuous variables and Pearson χ/Fischer exact test was used for categorical variables. Outcomes of interest were assessed using multivariable linear regressions for continuous variables and multivariable logistic regressions for categorical variables. RESULTS: There were 19,496 immediate autologous breast reconstruction patients, with 357 CTD and 19,139 non-CTD patients (2010-2014). The CTD patients had higher postoperative complication rates for infection (2.8% vs 0.8%, P < 0.001), wound dehiscence (1.4% vs 0.4%, P = 0.019), and bleeding (hemorrhage and hematoma) (6.7% vs 3.5%, P < 0.001). After multivariable analysis, CTD remained an independent risk factor for bleeding (odds ratio [OR], 1.568; 95% confidence interval [CI], 1.019-2.412). There were a total of 23,048 immediate implant breast reconstruction patients, with 431 CTD and 22,617 non-CTD patients (2010-2014). The CTD patients had a higher postoperative complication rate for wound dehiscence/complication (2.3% vs 0.6%, P < 0.001). They also experienced a longer length of stay (2.31 days vs 2.07 days, P < 0.001). After multivariable analysis, CTD remained an independent risk factor for wound dehiscence (OR, 4.084; 95% CI, 2.101-7.939) and increased length of stay by 0.050 days (95% CI, -0.081 to 0.181). CONCLUSIONS: Connective tissue disease patients who underwent autologous breast reconstruction had significantly higher infection, wound dehiscence, and bleeding rates, and those who underwent implant breast reconstruction had significantly higher wound dehiscence rates. Connective tissue diseases appear to be an independent risk factor for bleeding and wound dehiscence in autologous and implant breast reconstruction, respectively. This information may help clinicians be aware of this increased risk when determining patients for reconstruction.
引用
- Chen AD, Chi D, Wu WW, et al. The Influence of Connective Tissue Disease in Breast Reconstruction: A National Database Analysis. Ann Plast Surg. 2018. PMID: 29596085. doi:10.1097/SAP.0000000000001387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。